Antral Follicle Count (AFC)
AFC (Antral Follicle Count) is a transvaginal ultrasound measurement taken in the early follicular phase that counts small, fluid-filled follicles visible in both ovaries, typically 2 to 10 mm in diameter. The total count from both ovaries is the AFC. It reflects the number of follicles beginning development at the start of that cycle and serves as a marker of ovarian reserve alongside AMH and FSH.12
A lower AFC indicates fewer follicles beginning recruitment that cycle. Like AMH, AFC is a marker, not a diagnosis. The same number carries different clinical meaning depending on the patient's age, history, and other findings. A low AFC in a 38-year-old with a history of ovarian surgery is a different clinical picture than the same count in a 28-year-old with unexplained cycle irregularity. Context drives interpretation.
AFC varies more across cycles than AMH and is sensitive to technique, equipment calibration, and the timing within the follicular phase. A single AFC should not anchor irreversible conclusions about prognosis. Serial measurements across two or three cycles provide a more reliable picture of the ovary's typical recruitment pattern.
The count of follicles at the start of a cycle does not determine whether ovulation will be successful that cycle. Natural conception requires one well-developed follicle that ruptures and releases a healthy oocyte at the right time. The follicle maturation study tracks dynamic follicle growth and rupture through serial ultrasound. AFC tells the clinician what the ovary is starting with. The follicle maturation study tells what actually happens.2
When AFC is low, clinicians evaluate for correctable contributors: thyroid dysfunction, endometriosis affecting ovarian tissue, autoimmune conditions, and the suppressive effect of prior hormonal medications on follicle recruitment. A low AFC combined with other ovarian reserve markers and cycle chart data supports identification of what is driving the finding.
Cited in this entry
- Yin WW, Huang CC, Chen YR, Yu DQ, Jin M, Feng C. The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis. BMC Endocrine Disorders. 2022. https://pubmed.ncbi.nlm.nih.gov/35698127/
- Steiner AZ et al. Association Between Biomarkers of Ovarian Reserve and Infertility Among Older Women of Reproductive Age. JAMA. 2017. https://rrmacademy.org/library/association-between-biomarkers-of-ovarian-reserve-and-infertility-among-older-wo-reckxs7k83ltnbrhv/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.